Lupin launches Varenicline Tablets, 0.5 mg, 1 mg, ET HealthWorld


Mumbai: Lupin Limited announced the launch of Varenicline Tablets, 0.5 mg and 1 mg, after having received approval from the US Food and Drug Administration (US FDA).

Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix Tablets, 0.5 mg and 1 mg, of PF Prism CV. It is indicated for use as an aid to smoking cessation treatment.

Varenicline Tablets (RLD Chantix) had estimated annual sales of $412 million in the US (IQVIA MAT November 2023).

  • Published On Jan 10, 2024 at 06:12 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App


Leave a Reply

Your email address will not be published. Required fields are marked *